Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 7 studies | 30% ± 6% | |
| endothelial cell | 6 studies | 22% ± 6% | |
| type II pneumocyte | 6 studies | 37% ± 7% | |
| microglial cell | 5 studies | 25% ± 7% | |
| astrocyte | 5 studies | 33% ± 8% | |
| macrophage | 5 studies | 23% ± 4% | |
| type I pneumocyte | 5 studies | 26% ± 3% | |
| oligodendrocyte precursor cell | 4 studies | 22% ± 6% | |
| epithelial cell | 3 studies | 29% ± 10% | |
| GABAergic neuron | 3 studies | 35% ± 3% | |
| glutamatergic neuron | 3 studies | 38% ± 4% | |
| alveolar macrophage | 3 studies | 20% ± 4% | |
| monocyte | 3 studies | 21% ± 3% | |
| fibroblast | 3 studies | 18% ± 1% | |
| brush cell | 3 studies | 30% ± 9% | |
| adipocyte | 3 studies | 16% ± 0% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1788.48 | 1445 / 1445 | 100% | 6.01 | 183 / 183 |
| intestine | 100% | 1850.50 | 966 / 966 | 100% | 5.19 | 527 / 527 |
| lung | 100% | 2626.04 | 578 / 578 | 100% | 5.94 | 1155 / 1155 |
| stomach | 100% | 1162.43 | 359 / 359 | 100% | 4.92 | 286 / 286 |
| thymus | 100% | 1661.31 | 653 / 653 | 100% | 6.87 | 603 / 605 |
| skin | 100% | 1795.39 | 1809 / 1809 | 100% | 9.20 | 470 / 472 |
| kidney | 100% | 1279.73 | 89 / 89 | 100% | 4.73 | 897 / 901 |
| breast | 100% | 1716.32 | 459 / 459 | 100% | 4.66 | 1113 / 1118 |
| prostate | 100% | 1533.10 | 245 / 245 | 99% | 3.40 | 499 / 502 |
| uterus | 100% | 2021.48 | 170 / 170 | 99% | 5.00 | 456 / 459 |
| bladder | 100% | 1598.14 | 21 / 21 | 99% | 4.80 | 500 / 504 |
| brain | 98% | 840.94 | 2596 / 2642 | 100% | 5.66 | 705 / 705 |
| ovary | 100% | 1893.58 | 180 / 180 | 98% | 3.03 | 422 / 430 |
| pancreas | 99% | 705.25 | 324 / 328 | 98% | 4.57 | 175 / 178 |
| adrenal gland | 100% | 1184.96 | 257 / 258 | 96% | 3.21 | 220 / 230 |
| liver | 100% | 973.68 | 225 / 226 | 95% | 2.83 | 384 / 406 |
| adipose | 100% | 1529.15 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 2014.72 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 4.41 | 29 / 29 |
| muscle | 100% | 1529.99 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1665.84 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 5.51 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 1.39 | 1 / 1 |
| eye | 0% | 0 | 0 / 0 | 99% | 9.95 | 79 / 80 |
| heart | 97% | 924.50 | 838 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 87% | 1032.32 | 805 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0000023 | Biological process | maltose metabolic process |
| GO_0006491 | Biological process | N-glycan processing |
| GO_0004558 | Molecular function | alpha-1,4-glucosidase activity |
| GO_0030246 | Molecular function | carbohydrate binding |
| GO_0032450 | Molecular function | maltose alpha-glucosidase activity |
| Gene name | GANC |
| Protein name | Glucosidase alpha, neutral C Neutral alpha-glucosidase C (EC 3.2.1.20) Glucosidase, alpha neutral C |
| Synonyms | |
| Description | FUNCTION: Has alpha-glucosidase activity. . |
| Accessions | ENST00000440615.6 A0A0G2JLA2 H3BMW3 H3BRQ6 ENST00000318010.13 H3BMM3 ENST00000562170.5 ENST00000567784.5 ENST00000562859.5 H3BN99 E7EWB6 ENST00000570013.5 Q8TET4 ENST00000566442.5 Q2M2A3 ENST00000561871.1 |